TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›PVH
PVH logo

PVH

PVH CORP. /DE/

Next earnings Aug 24, 2026 · consensus $3.11 EPS, $2.11B rev

Last earnings +0.9% on 2026-06-03

Hold
$75.23
▲ +2.65%
$75.23▲ +14.65%
over 1Y
L $60.85H $98.77
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.6%
1W+4.5%
1M-22.6%
3M-2.4%
YTD+11.0%
1Y+14.6%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C-
Valuation
Overvalued
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 18 analysts
Buy

Iconic brands at 0.4x sales and a shrinking share count, but tariffs, FX-flattered growth and a $480M impairment muddy the picture.

Revenue $8.95B · FY2026

The read

Middling fundamentals and a rich price (~95% above fair value) leave little margin of safety — a wait-and-see.

PVH screens optically cheap — a $3.33B market cap on $8.95B of revenue (P/S 0.4) and $680M of operating cash flow imply a mid-teens cash-flow yield, and management is leaning into it with $578M of buybacks that pulled the share count down 13% YoY. Owning the Calvin Klein and Tommy Hilfiger marks (together >95% of revenue per the MD&A) is a durable franchise, and the headline P/E of 139.8 is distorted by a $480M goodwill and intangible asset impairment that crushed reported net income from $599M to $25M. Stripping that one-time charge, the underlying earnings power is intact, which is why the buyback at this level is rational.

That said, the operating picture is genuinely weakening. Reported revenue growth of 3.4% includes a $251M (3%) FX tailwind — ex-FX the top line was roughly flat, with EMEA and APAC declining in constant currency and the Americas leaning on the wholesale in-housing of women's product. Gross margin compressed 190 bps to 57.5%, and the MD&A flags an expected ~$195M gross-profit hit from tariffs in 2026 (vs. $69M in 2025), with refunds on previously paid tariffs explicitly NOT assumed. Long-term debt jumped 45% to $2.29B — partly funding the aggressive repurchases — while equity slipped 6.8%, so the balance sheet is moving in the wrong direction even as cash flow holds.

Is PVH a buy? The one-page verdict, explained →

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25FY26
Revenue$9.15B$9.02B$9.22B$8.65B$8.95B
Gross profit$5.32B$5.12B$5.36B$5.14B$5.15B
Operating income$1.08B$471M$929M$772M$231M
Net income$952M$200M$664M$599M$25.3M
Diluted EPS$13.25$3.03$10.76$10.56$0.52
Net margin10.4%2.2%7.2%6.9%0.3%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$5.07B
EV / EBITDA10.1
EV / Sales0.6
EV / FCF9.4
P / FCF6.4
PEG (trailing)—
Earnings yield0.7%
FCF yield15.5%

Quality & risk

ROIC (est.)2.6%
Free cash flow$538M
Total debt$2.30B
Net cash-$1.60B
Piotroski F-Score5/9

Capital returns

Buyback yield16.7%
Dividend yield (est.)—
Shareholder yield16.7%
Shares Δ YoY-13.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Agreement terminated2026-06-29
  2. 8-K Officer / director change2026-06-24

    Annual meeting vote results and officer/director changes disclosed

  3. 10-Q Quarterly report2026-06-05

    Q1 FY2026 10-Q filed; flags ~$195M expected tariff hit to FY2026 gross profit

  4. 8-K Earnings results2026-06-03

    Q1 FY2026 earnings release issued amid tariff and Mideast conflict headwinds

  5. DEF 14A Proxy statement2026-05-08

    Annual proxy filed for shareholder vote on directors and pay

  6. 8-K Other event2026-04-29

    Other-event disclosure between fiscal-year results and Q1 print

  7. 8-K Earnings results2026-03-31

    FY26 10-K: $480M impairment, op income -70%, LT debt +45%, $578M buybacks

  8. 10-K Annual report2026-03-31

    FY26 10-K: $480M impairment, op income -70%, LT debt +45%, $578M buybacks

  9. 8-K Charter / bylaws change2026-03-20

    Amendment to bylaws/articles of incorporation filed

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-242026-06-29open ↗4Period ending 2026-06-242026-06-26open ↗11-KPeriod ending 2025-12-312026-06-24open ↗11-KPeriod ending 2025-12-312026-06-24open ↗8-KPeriod ending 2026-06-182026-06-24open ↗4Period ending 2026-06-182026-06-23open ↗4Period ending 2026-06-182026-06-23open ↗4Period ending 2026-06-182026-06-23open ↗4Period ending 2026-06-182026-06-23open ↗4Period ending 2026-06-182026-06-23open ↗4Period ending 2026-06-182026-06-23open ↗4Period ending 2026-06-182026-06-23open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueC
GrowthF
ProfitabilityD
Financial healthA-
MomentumD
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗P/E below 25

Fair value est.

$3.78

Overvalued -95% vs price

cheapfair valueexpensive

Modified Graham: EPS $0.52 × (8.5 + 1.5 × 0.0% growth) × 0.85 quality = 7.3× multiple. An estimate, not a price target.

60.8552-week98.77
Revenue
$8.95B
+3.4% YoY
Net margin
0.3%
ROE
0.5%
P/E
144.7

SEC fundamentals · FY 2026

'22'23'24'25'26

■ revenue · ■ net income, by fiscal year

Revenue$8.95B+3.4%
Net income$25.3M-95.8%
Gross profit$5.15B+0.1%
Operating income$231M-70.1%
Diluted EPS$0.52-95.1%
Cash & equivalents$702M-6.2%
Total assets$11.7B+5.9%
Stockholders' equity$4.79B-6.8%
Gross: 57.5%Op.: 2.6%

Frequently asked

Is PVH CORP. /DE/ (PVH) a buy?
PVH currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Iconic brands at 0.4x sales and a shrinking share count, but tariffs, FX-flattered growth and a $480M impairment muddy the picture.
What is PVH's fair value?
A Modified-Graham model based on PVH's SEC fundamentals estimates a fair value of about $3.78. It is an estimate from reported earnings, not a price target.
Is PVH overvalued or undervalued?
Against a Modified-Graham fair-value estimate, PVH currently appears overvalued relative to its SEC-grounded earnings power.
What is PVH CORP. /DE/'s quality score?
PVH scores 53.92943909265735/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000078239, latest 10-Q filed 2026-06-05) · EODHD · Proprietary analysis · as of 6/25/2026, 1:37:09 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:37 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-18
SOURRY KNOX JUDITH AMANDA
Director
Award2.34K
2026-06-18
McPherson Amy
Director
Award2.34K
2026-06-18
McIntyre Geraldine Penny
Director
Award2.34K
2026-06-18
Gulliver Kate
Director
Award2.34K
2026-06-18
CHEEKS GEORGE
Director
Award2.34K
2026-06-18
Callinicos Brent
Director
Award2.34K
2026-06-18
CALBERT MICHAEL M
Director
Award4.93K

Dividends

Quarterly
Yield (TTM)
0.2%
Annual / share
$0.15
Last ex-date
2026-06-03
Last amount
$0.04
ex 2026-06-03paid 2026-06-24$0.04
ex 2026-03-04paid 2026-03-25$0.04
ex 2025-11-26paid 2025-12-17$0.04
ex 2025-09-03paid 2025-09-24$0.04
ex 2025-06-04paid 2025-06-25$0.04
ex 2025-03-05paid 2025-03-26$0.04

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-06-03Beat +14.5% est▲ +0.85%8-K ↗
2026-03-31Beat +14.5% est▲ +4.81%8-K ↗
2025-12-03Beat +24.4% est▲ +3.32%8-K ↗
2025-11-18Beat +24.4% est▼ -3.17%8-K ↗
2025-08-26—▲ +1.09%8-K ↗
2025-06-04—▼ -2.05%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

1 buy · 1 sell · 1 member · last 180d

+$0.00 net boughtlast trade 527d ago
$8.00K bought$8.00K sold
2026-01-13Julia LetlowBuy$1.00K–$15.0KPTR ↗
2026-01-13Julia LetlowSell$1.00K–$15.0KPTR ↗
2020-04-16Gilbert CisnerosBuy$1.00K–$15.0KPTR ↗
2015-04-05K. Michael ConawaySell$1.00K–$15.0KPTR ↗
2015-03-03K. Michael ConawayBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score54 vs 67
Revenue growth3.4% vs 7.5%
Net margin0.3% vs 10.0%
Return on equity0.5% vs 12.0%
P/E144.7 vs 26.2

News sentiment

EODHD · 36d
Bullish
+0.17
vs typical · 97 articles

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.